The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF
Abstract
Because mutations in RAS and BRAF represent the most common mutations found in human tumors, identification of inhibitors has been a major goal. Surprisingly, new oncogenic BRAF specific inhibitors inhibit cells transformed with mutated BRAF but paradoxically stimulate the growth of cells transformed with RAS. Here, we show that the mechanism for activation is via drug-induced dimer formation between CRAF and kinase suppressor of Ras (KSR)1. To understand the function of KSR1, we generated a KSR1 mutant that cannot bind ATP but stabilizes the closed, active conformation of KSR1. Molecular modeling suggested that the mutant stabilizes the two hydrophobic spines critical for the closed active conformation. We, therefore, could use the mutant to discriminate between the scaffold versus kinase functions of KSR1. The KSR1 mutant bound constitutively to RAF and mitogen-activated protein kinase kinase (MEK) but could not reconstitute activity suggesting that the catalytic activity of KSR1 is required for its function. Analogous mutations in BRAF and CRAF allowed us to test the generality of the model. The mutation induced changes consistent with the active, closed conformation of both kinases and confirmed that BRAF functions distinctly from CRAF in the MAP kinase pathway. Not only does this work suggest that KSR1 may function as a kinase, we anticipate that the mutation that we generated may be broadly applicable to stabilize the closed conformation of other kinases many of which may also form dimers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The constitutively activating L485F and L505F mutations found in BRAF (10, 11) further support an active role for the hydrophobic spine architecture in kinase activation and regulation.”
From A dynamic hydrophobic core orchestrates allostery in protein kinases (2017) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signaling dynamics of the KSR1 scaffold complex
McKay, M. M., Ritt, D. A., & Morrison, D. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901590106 · Cited by 163
Research works printed but not linked: 26
- MS Brose, et al., BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62, 6997–7000 (2002).
- 10.1038/nature08833 · DOI · Paper page
- 10.1016/j.cell.2009.12.040 · DOI · Paper page
- 10.1038/nature08902 · DOI · Paper page
- 10.1073/pnas.0711741105 · DOI · Paper page
- 10.1038/nature08314 · DOI · Paper page
- 10.1016/0092-8674(95)90206-6 · DOI · Paper page
- 10.1016/0092-8674(95)90205-8 · DOI · Paper page
- 10.1016/0092-8674(95)90204-X · DOI · Paper page
- 10.1073/pnas.94.24.12792 · DOI · Paper page
- 10.1128/MCB.22.9.3035-3045.2002 · DOI · Paper page
- 10.1016/j.cmet.2009.09.010 · DOI
- 10.1016/S0021-9258(18)42904-3 · DOI
- 10.1073/pnas.1003436107 · DOI
- 10.1016/j.tibs.2010.09.006 · DOI · Paper page
- 10.1016/S0092-8674(04)00215-6 · DOI · Paper page
- 10.1101/SQB.1997.062.01.041 · doi:10.1101/sqb.1997.062.01.041
- 10.1093/genetics/156.3.1231 · DOI
- 10.1016/j.gde.2006.12.005 · DOI · Paper page
- 10.1093/carcin/bgp337 · DOI
- 10.1016/j.molcel.2005.10.022 · DOI · Paper page
- 10.1172/JCI23441 · doi:10.1172/jci23441
- 10.1074/jbc.M008096200 · DOI
- 10.1242/jcs.114.9.1609 · DOI · Paper page
- 10.1128/MCB.19.8.5523 · DOI · Paper page
- 10.1101/gad.10.21.2684 · DOI · Paper page
Cited by
ERK1/2 MAP kinases: Structure, function, and regulation
Roskoski, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,650
Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information
Good, M. C., Zalatan, J. G., & Lim, W. A. (2011) · Science · doi:10.1126/science.1198701 · Cited by 885
Vemurafenib: the first drug approved for BRAF-mutant cancer
Bollag, G., Tsai, J., Zhang, J., Zhang, C., Ibrahim, P., Nolop, K., & Hirth, P. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3847 · Cited by 822
Regulation of RAF protein kinases in ERK signalling
Lavoie, H., & Therrien, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3979 · Cited by 702
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Degirmenci, U., Wang, M., & Hu, J. (2020) · Cells · doi:10.3390/cells9010198 · Cited by 534
Self-citation
Metadata
- Authors
- Hu, J., Yu, H., Kornev, A. P., Zhao, J., Filbert, E. L., Taylor, S. S., & Shaw, A. S.
- Affiliations
- Department of Pathology and Immunology, and
- Pharmacology, and
- Departments of Chemistry and Biochemistry,
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-03-25
- Volume
- 108
- Issue
- 15
- Pages
- 6067-6072
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 121
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF. https://app.cochat.ai/papers/10.1073/pnas.1102554108
- The paper
- Hu, J., Yu, H., Kornev, A. P., Zhao, J., Filbert, E. L., Taylor, S. S., & Shaw, A. S. (2011). Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1102554108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.